Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Novartis CAR-T cell therapy CTL019 unanimously (10-0) recommended for approval by FDA advisory commi

worldpharmanewsJuly 13, 2017

Tag: Novartis , CAR-T cell

PharmaSources Customer Service